Table 9. p values of multiple comparisons among tests evaluating sensitivity for active TB in active pulmonary TB patients (as reported in Table 6) in all patients with or without HIV-infection.
Single test | Combined tests | |||||||
TST | QFT-GIT | SM | TST+QFT-GIT | TST+SM | QFT-GIT+SM | QFT-GIT+SM+TST | ||
TST | NA | 0.20 | 0.69 | 0.04 | 0.08 | 0.005 ** | 0.0021 ** | |
QFT-GIT | – | NA | 0.06 | 0.63 | 0.81 | 0.20 | 0.11 | |
SM | – | – | NA | 0.009* | 0.02 | 0.0008 ** | 0.0003 ** | |
TST+QFT-GIT | – | – | – | – | – | – | 0.39 | |
TST+SM | – | – | – | – | – | – | 0.26 | |
QFT-GIT+SM | – | – | – | – | – | – | 1 |
Footnote: HIV: human immunodeficiency virus; TB: tuberculosis; TST (Tuberculin skin test); QFT-GIT: QuantiFERON® Gold in Tube (indeterminate results included as negative results; SM: smear microscopy.
Significant after Bonferroni correction for 5 multiple comparison, p value≤0.01;
significant after Bonferroni correction for 7 multiple comparison, p value≤0.007.